X4 Pharmaceuticals, Inc. (XFOR)
4.055
+0.02
(+0.37%)
USD |
NASDAQ |
Aug 24, 16:00
4.055
0.00 (0.00%)
After-Hours: 20:00
X4 Pharmaceuticals Market Cap : 389.74M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 388.30M |
| August 20, 2026 | 387.34M |
| August 19, 2026 | 399.84M |
| August 18, 2026 | 404.64M |
| August 17, 2026 | 413.29M |
| August 14, 2026 | 405.60M |
| August 13, 2026 | 412.33M |
| August 12, 2026 | 412.33M |
| August 11, 2026 | 411.37M |
| August 10, 2026 | 408.49M |
| August 07, 2026 | 445.97M |
| August 06, 2026 | 400.80M |
| August 05, 2026 | 398.88M |
| August 04, 2026 | 412.33M |
| August 03, 2026 | 385.77M |
| July 31, 2026 | 375.39M |
| July 30, 2026 | 377.28M |
| July 29, 2026 | 377.28M |
| July 28, 2026 | 370.68M |
| July 27, 2026 | 371.62M |
| July 24, 2026 | 363.13M |
| July 23, 2026 | 376.34M |
| July 22, 2026 | 348.51M |
| July 21, 2026 | 348.04M |
| July 20, 2026 | 347.10M |
| Date | Value |
|---|---|
| July 17, 2026 | 360.30M |
| July 16, 2026 | 361.24M |
| July 15, 2026 | 367.85M |
| July 14, 2026 | 379.17M |
| July 13, 2026 | 381.99M |
| July 10, 2026 | 415.95M |
| July 09, 2026 | 373.51M |
| July 08, 2026 | 373.51M |
| July 07, 2026 | 371.62M |
| July 06, 2026 | 380.11M |
| July 02, 2026 | 389.54M |
| July 01, 2026 | 385.30M |
| June 30, 2026 | 440.47M |
| June 29, 2026 | 398.97M |
| June 26, 2026 | 379.17M |
| June 25, 2026 | 376.34M |
| June 24, 2026 | 385.77M |
| June 23, 2026 | 377.28M |
| June 22, 2026 | 388.60M |
| June 18, 2026 | 398.03M |
| June 17, 2026 | 381.99M |
| June 16, 2026 | 381.05M |
| June 15, 2026 | 384.82M |
| June 12, 2026 | 377.28M |
| June 11, 2026 | 365.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 1.915B |
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
| Oncolytics Biotech, Inc. | 105.94M |
| Sangamo Therapeutics, Inc. | 58.95M |
| Anixa Biosciences, Inc. | 122.97M |
Market Cap Related Metrics
| PS Ratio | 26.00 |
| Price to Book Value | 2.507 |
| Price | 4.055 |
| Earnings Yield | -29.44% |